1-Thioglycerol: inhibitor of glycerol kinase activity in vitro and in situ.
The infantile form of glycerol kinase (GK) deficiency (McKusick No. 30703) (1) is characterized by adrenal cortical insufficiency, adrenal hypoplasia and developmental delay. The underlying biochemical mechanism(s) responsible for the observed clinical presentations are undetermined. Pursuant to our examination of the molecular pathogenesis of this enzyme deficiency, we have endeavored to develop a model for this disorder. 1-thioglycerol (1-TG) was investigated as a potential GK inhibitor in adrenal gland, an organ consistently affected, and in cultured fibroblasts, available from affected individuals. In 105,000 g bovine adrenal supernatant the Ki for 1-TG was 1.9 mM. In human fibroblast 105,000 g supernatant, the Ki for 1-TG was 3.4 mM. In both tissues the inhibition was purely competitive with respect to glycerol. Using incorporation of [14C(U)]-glycerol into protein as an index of GK activity in situ in human skin fibroblasts, GK deficient fibroblasts incorporate less than 10% of that observed in normal fibroblasts. Addition of 1-TG to normal fibroblasts resulted in inhibited incorporation rates. The specificity of these effects in situ was examined. Our findings indicate that 1-TG may be a suitable inhibitor of GK activity for the development of a model for glycerol kinase deficiency.
D000311:Adrenal Glands / Q000201:enzymology; D000818:Animals; D001667:Binding, Competitive; D002417:Cattle; D002478:Cells, Cultured; D005347:Fibroblasts / Q000201:enzymology; D005990:Glycerol / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D005991:Glycerol Kinase / Q000037:antagonists & inhibitors / Q000172:deficiency*; D006801:Humans; D007930:Leucine / Q000378:metabolism; D010770:Phosphotransferases / Q000172:deficiency*
C009465:thioglycerol; D010770:Phosphotransferases; D005991:Glycerol Kinase; D007930:Leucine; D005990:Glycerol